SUN-414 Tyrosine Kinase Inhibitors Induced Thyroid Dysfunction: An Experience from a Tertiary Care Hospital

Tyrosine kinase inhibitors (TKI) belong to a new class of molecular multi-targeted anticancer therapy which targets different growth factor receptors and hence attenuates cancer cell survival and growth. TKI-induced thyroid dysfunction is recognized as a common adverse effect of treatment., but the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wangnoo, Subhash Kumar, Siddiqui, Mohammad Asim, Pamnani, Harsha, Usman, Khwaja Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Thyroid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208000/
http://dx.doi.org/10.1210/jendso/bvaa046.1587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208000/
http://dx.doi.org/10.1210/jendso/bvaa046.1587

Ejemplares similares